Quicksilver Scientific

Free Shipping on Orders over $99 (Excludes )

0
0
Subtotal: 0.00

No products in the cart.

D3K2 References quicksilverscientific.com/d3k2references/

  1. Wilson LR et al. Vitamin D deficiency as a public health issue: using vitamin D 2 or vitamin D 3 in future fortification strategies. Proceedings of the Nutrition Society. 2017 Aug;76(3):392-9. View Abstract
  2. Holick MF. The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention. Reviews in Endocrine and Metabolic Disorders. 2017 Jun 1;18(2):153-65. View Abstract
  3. Parva NR et al.Prevalence of vitamin D deficiency and associated risk factors in the US population (2011-2012). Cureus. 2018 Jun 5;10(6):e2741. View Abstract
  4. Norman AW. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. The American journal of clinical nutrition. 2008 Aug 1;88(2):491S-9S. View Abstract
  5. Melamed ML et al. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008 Aug 11;168(15):1629-37. View Abstract
  6. Tripkovic L et al Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr. 2012;95(6):1357–1364. View Full Paper
  7. Cranney A et al. Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess . 2007 Aug;(158):1–235. View Abstract 
  8. White JH. Vitamin D signaling, infectious diseases, and regulation of innate immunity. Infect Immun. 2008 Sep;76(9):3837-43. View Full Paper
  9. Prietl B et al. Vitamin D and immune function. Nutrients. 2013 Jul 5;5(7):2502–21. View Abstract
  10. Vanherwegen A-S et al. Regulation of immune function by vitamin D and its uses in immunity. Endocrinol Metab Clin North Am. 2017 Dec;46(4):1061–94. View Abstract
  11. Munger KL, Levin LI, Hollis BW, et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006 Dec 20;296(23):2832–8. View Absract
  12. Calvo MS, Whiting SJ, Barton CN. Vitamin D intake: a global perspective of current status. J Nutr. 2005;135(2):310-316. [Article]
  13. Zhang R, Naughton DP. Vitamin D in health and disease: current perspectives. Nutr J. 2010;9:65. [Article]
  14. Zdrenghea MT, et al. Vitamin D modulation of innate immune responses to respiratory viral infections. Rev Med Virol [Internet]. 2017 Jan;27(1). View Abstract
  15. Xiao L, et al. Vitamin D supplementation for the prevention of childhood acute respiratory infections: a systematic review of randomised controlled trials. Br J Nutr. 2015 Aug 27:1-9. View Abstract
  16. Martineau AR et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017 Feb 15;356:i6583. View Absract
  17. Yildiz I, Unuvar E, Zeybek U, et al. The role of vitamin D in children with recurrent tonsillopharyngitis.  Ital J Pediatr. 2012 Jun 8;38:25.  View Full Paper
  18. Ginde AA, Mansbach JM, Camargo CA Jr. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2009 Feb 23;169(4):384-90. View Full Paper
  19. Quraishi SA, Bittner EA, Christopher KB, Camargo CA Jr. Vitamin D status and community-acquired pneumonia: results from the third National Health and Nutrition Examination Survey. PLoS One. 2013 Nov 15;8(11):e81120. View Full Paper
  20. Anglin RE, Samaan Z, Walter SD, McDonald SD. Vitamin D deficiency and depression in adults: systematic review and meta-analysis. Br J Psychiatry. 2013 Feb;202:100-7. View Full Paper
  21. Anglin RES et al. Vitamin D deficiency and depression in adults: systematic review and meta-analysis. Br J Psychiatry. 2013 Feb;202:100–7. [Article]
  22. Shaffer JA et al. Vitamin D supplementation for depressive symptoms: a systematic review and meta-analysis of randomized controlled trials. Psychosom Med. 2014 Apr;76(3):190–6. View Abstract
  23. Penckofer S et al. Vitamin D Supplementation Improves Mood in Women with Type 2 Diabetes. J Diabetes Res. 2017 Sep 7;2017:8232863. View Abstract
  24. Gloth FM 3rd, Alam W, Hollis B. Vitamin D vs broad spectrum phototherapy in the treatment of seasonal affective disorder. J Nutr Health Aging. 1999;3(1):5-7. View Abstract
  25. Landel V et al. Vitamin D, cognition and Alzheimer’s Disease: the therapeutic benefit is in the D-Tails. J. Alzheimers Dis. 2016;53(2):419–444. View Full Paper
  26. Goodwill AM. A systematic review and meta-analysis of the effect of low vitamin D on cognition. J Am Geriatr Soc. 2017 Oct;65(10):2161-2168. View Abstract
  27. Morello M. Vitamin D improves neurogenesis and cognition in a mouse model of Alzheimer’s disease. Mol Neurobiol. 2018 Aug;55(8):6463-6479. View Full Paper
  28. Gangwar AK et al. Role of Vitamin-D in the prevention and treatment of Alzheimer’s disease. Indian J Physiol Pharmacol. 2015 Jan;59(1):94–9. View Abstract
  29. Yin Yet al. Nutrient biomarkers and vascular risk factors in subtypes of mild cognitive impairment: a cross-sectional study. J Nutr Health Aging. 2015 Jan;19(1):39–47. View Abstract
  30. Wood JM et al. Vitamin D and neurocognitive disorder due to Alzheimer’s disease: A review of the literature. Ann Clin Psychiatry. 2015 Aug;27(3):206–12. View Abstract
  31. Mheid IA et al. Vitamin D and cardiovascular disease. State-of-the-Art-Review. Journal of the American College of Cardiology 2017 (70):1: 89-100 View Abstract
  32. Rai V et al. Role of vitamin D in cardiovascular diseases.Endocrinol Metab Clin North Am. 2017 Dec;46(4):1039-1059 View Abstract
  33. Brinkley DM et al. Vitamin D and heart failure. Curr Heart Fail Rep. 2017 Oct;14(5):410-420. View Abstract
  34. Khan A et al. Nanomedical studies of the restoration of nitric oxide/peroxynitrite balance in dysfunctional endothelium by 1,25-dihydroxy vitamin D3 – clinical implications for cardiovascular diseases.Int J Nanomedicine. 2018 Jan 19;13:455-466. View Abstract
  35. Mathyssen C et al. Vitamin D supplementation in respiratory diseases: evidence from randomized controlled trials. Pol Arch Intern Med. 2017 Nov 30;127(11):775–84. View Abstract
  36. Burkes RM et al. Associations among 25-Hydroxyvitamin D levels, lung function, and exacerbation outcomes in COPD: An analysis of the SPIROMICS cohort. Chest. 2020 Jan 17. View Abstract
  37. Sluyter JD et al. Effect of monthly, high-dose, long-term vitamin D on lung function: a randomized controlled trial. Nutrients [Internet]. 2017 Dec 13;9(12). View Abstract
  38. Bügel S. Vitamin K and bone health in adult humans. Vitam Horm. 2008;78:393-416. View Abstract
  39. Iwamoto I, Kosha S, Noguchi S-i. A longitudinal study of the effect of vitamin K2 on bone mineral density in postmenopausal women a comparative study with vitamin D3 and estrogen-progestin therapy. Maturitas. 1999;31(2):161-164. [Article]
  40. Onodera K, Takahashi A, Sakurada S et al. Effects of phenytoin and/or vitamin K2 (menatetrenone) on bone mineral density in the tibiae of growing rats. Life Sciences. 2002;70(13):1533-1542. [Article]
  41. Spector AA et al. Membrane lipid composition and cellular function. J Lipid Res. 1985 Sep;26(9):1015-35 View Full Paper
  42. Porter CJ. Drug delivery to the lymphatic system. Crit Rev Ther Drug Carrier Syst. 1997;14(4):333-93 View Full Paper
  43. Ahn H et al. Liposomal delivery systems for intestinal lymphatic drug transport. Biomater Res. 2016 Nov 23;20:36 View Full Paper
  44. Alyautdin R et al. Nanoscale drug delivery systems and the blood brain barrier. Int J Nanomedicine. 2014 Feb 7;9:795-811 View Full Paper

Microb-Manager™ References quicksilverscientific.com/microbmanagerreferences/

  1. Aslam B, et al. Antibiotic resistance: a rundown of a global crisis. Infect Drug Res. 2018; 11: 1645-1658.
  2. “Antibiotic/antimicrobial Resistance (AR/AMR): Biggest threats and data.” Centers for Disease Control and Prevention. 10 Sept 2018. https://www.cdc.gov/drugresistance/biggest_threats.html.
  3. Gupta PD, Birdi TJ. Development of botanicals to combat antibiotic resistance. J Ayurveda Integr Med. 2017; 8(4): 266-275.
  4. Feng J, et al. A drug combination screen identifies drugs active against amoxicillin-induced round bodies of in vitro Borrelia burgdorferi persisters from an FDA drug library. Front Microbiol. 2016; 7: 743.
  5. Kim WS, et al. Anti-inflammatory, antioxidant and antimicrobial effects of artemisinin extracts from artemisia annua L. Korean J Physiol Pharmacol. 2015; 19(1): 21-27.
  6. Appalasamy S, et al. Antimicrobial activity of artemisinin and precursor derived from in vitro plantlets of artemisia annua L. Biomed Res Int. 2014; 2014: 215872.
  7. Fiamegos YC, et al. Antimicrobial and efflux pump inhibitory activity of caffeoylquinic acids from Artemisia absinthium against gram-positive pathogenic bacteria. PLoS One. 2011; 6(4): e18127.
  8. Liu X, et al. Antifungal compounds against Candida infections from traditional Chinese medicine. Biomed Res Int. 2017; 2017: 4614183.
  9. Dziedzic A, et al. Inhibition of oral Streptococci growth induced by the complementary action of berberine chloride and antibacterial compounds. Molecules. 2015; 20(8): 13705-13724.
  10. Feng J, et al. Selective essential oils from spice or culinary herbs have high activity against stationary phase and biofilm Borrelia burgdorferiFront Med (Lausanne). 2017; 4: 169.
  11. Rao PV, Gan SH. Cinnamon: A multifaceted medicinal plant. Evid Based Complement Alternat Med. 2014; 2014: 642942.
  12. “Cannabidiol is a powerful new antibiotic.” American Society for Microbiology. 23 June 2019. https://www.asm.org/Press-Releases/2019/June/Cannabidiol-is-a-Powerful-New-Antibiotic.
  13. Teow SY, et al. Antibacterial action of curcumin against Staphylococcus aureus: A brief review. J Trop Med. 2016; 2016: 2853045.
  14. Moghadamtousi SZ, et al. A review on antibacterial, antiviral, and antifungal activity of curcumin. Biomed Res Int. 2014; 2014: 186864.
  15. Dou Y, et al. Curcumin attenuates collagen-induced inflammatory response through the “gut-brain axis.” J Neuroinflamm. 2018; 5: 6.
  16. Isacchi B, et al. Artemisinin and artemisinin plus curcumin liposomal formulations: Enhanced antimalarial efficacy against Plasmodium berghei-infected mice. Eur J Pharm Biopharm. 2012; 80(3): 528-534.
  17. Toden S, et al. Essential turmeric oils enhance anti-inflammatory efficacy of curcumin in dextran sulfate sodium-induced colitis. Sci Rep. 2017; 7: 814.
  18. Ismail SM, et al. Antimicrobial activity of frankincense of Boswellia serrata. Int J Curr Microbiol App Sci. 2014; 3(10): 1095-1101.
  19. Raja AF, et al. Acetyl-11-keto-β-boswellic acid (AKBA); targeting oral cavity pathogens. BMC Res Notes. 2011; 4: 406.
  20. Siddiqui MZ. Boswellia Serrata, a potential antiinflammatory agent: An overview. Indian J Pharm Sci. 2011; 73(3): 255-261.
  21. Umar S, et al. Boswellia serrata extract attenuates inflammatory mediators and oxidative stress in collagen induced arthritis. Phytomedicine. 2014; 21(6): 847-856.
  22. Raja AF, et al. Antistaphylococcal and biofilm inhibitory activities of acetyl-11-keto-β-boswellic acid from Boswellia serrata. BMC Microbiol. 2011; 11: 54.
  23. Haroyan A, et al. Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study. BMC Complement Altern Med. 2018; 18: 7.
  24. De Oliveira DR, et al. In vitro antimicrobial and modulatory activity of the natural products silymarin and silibinin. Biomed Res Int. 2015; 2015: 292797.
  25. Weng Z, et al. Quercetin is more effective than cromolyn in blocking human mast cell cytokine release and inhibits contact dermatitis and photosensitivity in humans. PLoS One. 2012; 7(3): e33805.
  26. Johnzon CF, et al. The role of mast cells in bacterial infection. Am J Pathol. 2016; 186(1): 4-14.
  27. Okhuarobo A, et al. Harnessing the medicinal properties of Andrographis paniculata for diseases and beyond: a review of its phytochemistry and pharmacology. Asian Pac J Trop Dis. 2014; 4(3): 213-222.
  28. Pongtuluran OB, et al. Antiviral and immunostimulant activities of Andrographis paniculata. HAYATI J Biosci. 2015; 22(2): 67-72.
  29. Mishra PK, et al. Antibacterial activity of Andrographis paniculata (Burm. f.) Wall ex Nees leaves against clinical pathogens. J Pharm Res. 2013; 7(5): 459-462.
  30. Al-Hariri M. Immune’s-boosting agent: Immunomodulation potentials of propolis. J Family Community Med. 2019; 26(1): 57-60.
  31. Przybylek I, Karpinski TM. Antibacterial properties of propolis. Molecules. 2019; 24(11): 2047.
  32. Silvo-Carvalho L, et al. Propolis: A complex natural product with a plethora of biological activities that can be explored for drug development. Evid Based Complement Alternat Med. 2015; 2015: 206439.
  33. Aderibigbe BA. Design of drug delivery systems containing artemisinin and its derivatives. Molecules. 2017; 22(2): 323.
  34. Zgair A, et al. Dietary fats and pharmaceutical lipid excipients increase systemic exposure to orally administered cannabis and cannabis-based medicines. Am J Transl Res. 2016; 8(8): 3448-3459.
  35. Luo X, et al. Preparation of berberine hydrochloride long-circulating liposomes by ionophore A23187-mediated ZnSO4 gradient method. Asian J Pharm Sci. 2013; 8(4): 261-266.
  36. Cheng C, et al. Improved bioavailability of curcumin in liposomes prepared using a pH-driven, organic solvent-free, easily scalable process. RSC Advances. 2017; 7: 25978-25986.
  37. Yao L, et al. Novel berberine derivatives: Design, synthesis, antimicrobial effects, and molecular docking studies. Chin J Nat Medicines. 2018; 16(10): 774-781.
  38. Yu Y, et al. Anti-inflammatory effects of curcumin in microglial cells. Front Pharmacol. 2018; 9: 386.
  39. Nie X, et al. Attenuation of innate immunity by andrographolide derivatives through NF-κB signaling pathway. Sci Rep. 2017; 7: 4738.
  40. Orsatti CL, et al. Propolis immunomodulatory action in vivo on Toll-like receptors 2 and 4 expression and on pro-inflammatory cytokines production in mice. Phytother Res. 2010; 24(8): 1141-1146.
  41. Governa P, et al. Effects of Boswellia Serrata Roxb. and Curcuma longa L. in an in vitro intestinal inflammation model using immune cells and Caco-2. Pharmaceuticals (Basel). 2018; 11(4): 126.
  42. Vargas-Mendoza N, et al. Hepatoprotective effect of silymarin. World J Hepatol. 2014; 6(3): 144-149.

Vitamin C References quicksilverscientific.com/vitamincreferences/

  1. Pehlivan FE. Vitamin C: An antioxidant agent. InTechOpen. 2017; [online]
  2. Lenton KJ, et al. Vitamin C augments lymphocyte glutathione in subjects with ascorbate deficiency. Am J Clin Nutr. 2003; 77(1): 189-195.
  3. Carpenter KJ. The discovery of vitamin C. Ann Nutr Metab. 2012; 61(3): 259-264.
  4. Pullar JM, et al. The roles of vitamin C in skin health. Nutrients. 2017; 9(8): 866.
  5. Malmir H, et al. Vitamin C intake in relation to bone mineral density and risk of hip fracture and osteoporosis: a systematic review and meta-analysis of observational studies. Br J Nutr. 2018; 119(8): 847-858.
  6. Panush RS, et al. Modulation of certain immunologic responses by vitamin C. III. Potentiation of in vitro and in vivo lymphocyte responses. Int J Vitam Nutr Res Suppl. 1982; 23: 35-47.
  7. Elste V, et al. Emerging evidence on neutrophil motility supporting its usefulness to define vitamin C intake requirements. Nutrients. 2017; 9(5): pii: E503.
  8. Hemila H. Vitamin C and infections. Nutrients. 2017; 9(4): 339.
  9. Travica N, et al. Plasma vitamin C concentrations and cognitive function: A cross-sectional study. Front Aging Neurosci. 2019; 11: 72.
  10. Harrison FE, May JM. Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2. Free Radic Biol Med. 2009; 46(6): 719-730.
  11. Kocot J, et al. Does vitamin C influence neurodegenerative diseases and psychiatric disorders? Nutrients. 2017; 9(7): pii: E659.
  12. Gillberg L, et al. Vitamin C – A new player in regulation of the cancer epigenome. Semin Cancer Biol. 2018; 51: 59-67.
  13. Young JI, et al. Regulation of the epigenome by vitamin C. Annu Rev Nutr. 2015; 35: 545-564.
  14. Mustafi S, et al. Vitamin C supplementation expands the therapeutic window of BETi for triple negative breast cancer. E Bio Medicine. 2019; 43: 102-210.
  15. Mustafi S, et al. Vitamin C sensitizes melanoma to BET inhibitors. Cancer Res. 2018; 78(2): 572-583.
  16. Pires AS, et al. Ascorbic acid chemosensitizes colorectal cancer cells and synergistically inhibits tumor growth. Front Physiol. 2018; 9: 911.
  17. May JM, Harrison FE. Role of vitamin C in the function of the vascular endothelium. Antioxid Redox Signal. 2013; 19(17): 2068-2083.
  18. Ashor AW, et al. Effect of vitamin C on endothelial function in health and disease: a systematic review and meta-analysis of randomised controlled trials. Atherosclerosis. 2014; 235(1): 9-20.
  19. Juraschek SP, et al. Effects of vitamin C supplementation on blood pressure: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2012; 95(5): 1079-1088.
  20. Ellulu MS, et al. Effect of vitamin C on inflammation and metabolic markers in hypertensive and/or diabetic obese adults: a randomized controlled trial. Drug Des Devel Ther. 2015; 9: 3405-3412.
  21. Basili S, et al. Intravenous ascorbic acid infusion improves myocardial perfusion grade during elective percutaneous coronary intervention: relationship with oxidative stress markers. JACC Cardiovasc Interv. 2010; 3(2): 221-229.
  22. Dingchao H, et al. The protective effects of high-dose ascorbic acid on myocardium against reperfusion injury during and after cardiopulmonary bypass. Thorac Cardiovasc Surg. 1994; 42(5): 276-278.
  23. Schleicher RL, et al. Serum vitamin C and the prevalence of vitamin C deficiency in the United States: 2003-2004 National Health and Nutrition Examination Survey (NHANES). Am J Clin Nutr. 2009; 90(5): 1252-1263.
  24. Nishikawa F, et al. Ascorbate metabolism in harvested broccoli. J Experiment Bot. 2003; 54(392): 2439-2448.
  25. Sapei L, Hwa L. Study on the kinetics of vitamin C degradation in fresh strawberry juices. Procedia Chem. 2014; 9: 62-68.
  26. Li Y, Schellhorn HE. New developments and novel therapeutic perspectives for vitamin C. J Nutr. 2007; 137(10): 2171-2184.
  27. Davis JL, et al. Liposomal-encapsulated ascorbic acid: Influence on vitamin C bioavailability and capacity to protect against ischemia–reperfusion injury. Nutr Metab Insights. 2016; 9: 25-30

0
    0
    Your Cart
    You're 99.00 away from free shipping.
    Your cart is empty
      Calculate Shipping
      Apply Coupon

      to your account for access to our

      Memorial Day

      Weekend Sale!

      Don’t have an account? Sign up here!